• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Replimune Group, Inc. - Common Stock (NQ:REPL)

    8.230 -0.690 (-7.74%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,134,187
    Open 8.820
    Bid (Size) 8.230 (200)
    Ask (Size) 8.550 (10,000)
    Prev. Close 8.920
    Today's Range 8.225 - 8.830
    52wk Range 2.685 - 14.80
    Shares Outstanding 46,772,263
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From Replimune, Inc.
    Via GlobeNewswire
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
     
    Via Benzinga

    Performance

    YTD
    -7.5%
    -7.5%
    1 Month
    -23.3%
    -23.3%
    3 Month
    +80.1%
    +80.1%
    6 Month
    -20.8%
    -20.8%
    1 Year
    -26.5%
    -26.5%

    More News

    Read More
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    What Is Driving Replimune Stock’s 98% Surge Today? ↗
    Via Stocktwits
    News headline image
    Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025)
    From Replimune, Inc.
    Via GlobeNewswire
    News headline image
    Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update
    From Replimune, Inc.
    Via GlobeNewswire
    News headline image
    Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday ↗
    Via Benzinga
    News headline image
    The Best AI for Picking Stocks, Ranked by Performance ↗
    Via MarketBeat
    Topics Artificial Intelligence ETFs
    News headline image
    Why Replimune Stock Was Soaring Today ↗
    Via The Motley Fool
    News headline image
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Via Benzinga
    News headline image
    These stocks are the most active in today's session ↗
    Via Chartmill
    News headline image
    Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session. ↗
    Via Chartmill
    News headline image
    Here's Why Replimune Group (REPL) Stock Is Up Over 100% Today ↗
    Via Benzinga
    News headline image
    Gapping stocks in Monday's session ↗
    Via Chartmill
    News headline image
    WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday ↗
    Via Benzinga
    Topics Artificial Intelligence
    News headline image
    Dow Jumps Over 200 Points; Cleveland-Cliffs Shares Jump After Q3 Results ↗
    Via Benzinga
    Topics Stocks
    News headline image
    These stocks are moving in today's pre-market session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
    From Replimune, Inc.
    Via GlobeNewswire
    News headline image
    Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
    From Replimune, Inc.
    Via GlobeNewswire
    News headline image
    REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Replimune Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
    From Faruqi & Faruqi, LLP
    Via Business Wire
    News headline image
    REPLIMUNE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Replimune Group, Inc. Investors to Contact the Firm Regarding Class Action Lawsuit
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Frequently Asked Questions

    Is Replimune Group, Inc. - Common Stock publicly traded?
    Yes, Replimune Group, Inc. - Common Stock is publicly traded.
    What exchange does Replimune Group, Inc. - Common Stock trade on?
    Replimune Group, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Replimune Group, Inc. - Common Stock?
    The ticker symbol for Replimune Group, Inc. - Common Stock is REPL on the Nasdaq Stock Market
    What is the current price of Replimune Group, Inc. - Common Stock?
    The current price of Replimune Group, Inc. - Common Stock is 8.230
    When was Replimune Group, Inc. - Common Stock last traded?
    The last trade of Replimune Group, Inc. - Common Stock was at 01/08/26 04:00 PM ET
    What is the market capitalization of Replimune Group, Inc. - Common Stock?
    The market capitalization of Replimune Group, Inc. - Common Stock is 384.94M
    How many shares of Replimune Group, Inc. - Common Stock are outstanding?
    Replimune Group, Inc. - Common Stock has 385M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.